Literature DB >> 29327681

Updated National Comprehensive Cancer Network guidelines for treatment of head and neck cancers 2010-2017.

Małgorzata Wierzbicka1, Joanna Napierała1.   

Abstract

INTRODUCTION: The diagnostic and therapeutic recommendations have been changing over the years to improve treatment outcomes and quality of life of Head and Neck Cancer (HNC) patients. AIM: The aim of this study was to present currently recommended Head and Neck Cancer treatment guidelines based on the literature review with particular emphasis on novel approaches the NCCN algorithms.
MATERIAL AND METHODS: The review of literature covering articles published in the last five years and pointing out essential changes in HNC treatment regarding evidence based medicine. The study focused on the analysis of novel approaches for the particular primaries, the implementation of biological therapies and personalized cancer therapies.
RESULTS: Updates in the oncological NCCN guidelines for all ENT primaries except major salivary glands and subglottis are based on knowledge derived from the basic sciences, clinical trials and the best evidence available currently. The latest recommendations emphasize value of biological therapies use.

Entities:  

Keywords:  biological therapy; head and neck cancers treatment guidelines; personalized treatment; recommendations

Mesh:

Year:  2017        PMID: 29327681     DOI: 10.5604/01.3001.0010.7193

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  11 in total

1.  Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.

Authors:  A Jajodia; G Mandal; V Yadav; J Khoda; J Goyal; S Pasricha; S Puri; A Dewan
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-23       Impact factor: 4.966

2.  Sarcopenia is associated with higher toxicity and poor prognosis of nasopharyngeal carcinoma.

Authors:  Xin Hua; Jun-Fang Liao; Xin Huang; Han-Ying Huang; Wen Wen; Zhi-Qing Long; Ling Guo; Zhong-Yu Yuan; Huan-Xin Lin
Journal:  Ther Adv Med Oncol       Date:  2020-08-18       Impact factor: 8.168

3.  Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.

Authors:  Xin Hua; Wang-Zhong Li; Xin Huang; Wen Wen; Han-Ying Huang; Zhi-Qing Long; Huan-Xin Lin; Zhong-Yu Yuan; Ling Guo
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

4.  A Model Combining Skeletal Muscle Mass and a Hematological Biomarker to Predict Survival in Patients With Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.

Authors:  Han-Ying Huang; Fei Lin; Xiao-Yu Chen; Wen Wen; Shuang-Yan Xie; Zhi-Qing Long; Ling Guo; Huan-Xin Lin
Journal:  Front Oncol       Date:  2021-05-18       Impact factor: 6.244

Review 5.  Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review.

Authors:  Tanaya S Deshpande; Pierre Blanchard; Li Wang; Robert L Foote; Xiaodong Zhang; Steven J Frank
Journal:  Curr Treat Options Oncol       Date:  2018-11-09

6.  Translation and cross-cultural adaption of the Chinese version of the Vanderbilt Head and Neck Symptom Survey version 2.0: a tool for oral symptom assessment in head and neck cancer patients.

Authors:  Min Jin; Li Sun; Rui Meng; Wenjing Wang; Rui Sun; Jing Huang; You Qin; Bian Wu; Qian Ding; Gang Peng; Tao Zhang; Kunyu Yang
Journal:  Health Qual Life Outcomes       Date:  2021-01-21       Impact factor: 3.186

Review 7.  Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data.

Authors:  Mei Mei; Yu-Huan Chen; Tian Meng; Ling-Han Qu; Zhi-Yong Zhang; Xiao Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-12-08       Impact factor: 8.168

8.  Retrospective analysis of 98 cases of maxillary sinus squamous cell carcinoma and therapeutic exploration.

Authors:  Yu Wang; Rong Yang; Minghui Zhao; Wenyu Guo; Lun Zhang; Wenchao Zhang; Xudong Wang
Journal:  World J Surg Oncol       Date:  2020-05-06       Impact factor: 2.754

9.  Characterisation of a subpopulation of CD133+ cancer stem cells from Chinese patients with oral squamous cell carcinoma.

Authors:  Zhen Ma; Chong Zhang; Xiaotong Liu; Fang Fang; Shiqi Liu; Xianxiang Liao; Shicheng Tao; Huaming Mai
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

10.  Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database.

Authors:  Xinrong Li; Kaibo Guo; Yuqian Feng; Yong Guo
Journal:  Cancer Med       Date:  2020-09-15       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.